Newsroom

May 5, 2022
First quarter 2022 net sales of $1.15 billion , an increase of 4% year-over-year; GAAP net loss attributable to Covetrus of $(2) million Non-GAAP organic net sales growth of 6% year-over-year Non-GAAP adjusted EBITDA increased 11% year-over-year to $63 million Full-year 2022 non-GAAP organic net
March 16, 2022
Former Chief Economist at the AVMA to Lead Covetrus Subsidiary PORTLAND, Maine --(BUSINESS WIRE)--Mar. 16, 2022-- Veterinary Study Groups, Inc. (VSG), a subsidiary of Covetrus ® (NASDAQ: CVET), a global leader in animal-health technology and services, has named Matt Salois , Ph.D.
February 24, 2022
Fourth quarter 2021 net sales of $1.12 billion , unchanged year-over-year; GAAP net loss attributable to Covetrus of $(3) million Non-GAAP organic net sales growth of 2% year-over-year Non-GAAP adjusted EBITDA increased 13% year-over-year to $63 million Full-year 2021 net sales of $4.58 billion ,
January 26, 2022
Long-time Nestlé S.A. executive to manage global growth for Covetrus portfolio PORTLAND, Maine --(BUSINESS WIRE)--Jan. 26, 2022-- Covetrus ® (NASDAQ: CVET), a global leader in animal-health technology and services, today announced the appointment of César França as President, Global Proprietary
January 12, 2022
Covetrus Pulse ™ will unite best of Covetrus offerings into all-in-one cloud platform PORTLAND, Maine --(BUSINESS WIRE)--Jan. 12, 2022-- Covetrus® (NASDAQ: CVET), a global leader in animal-health technology and services, today announced the launch of Covetrus Pulse™, an innovative cloud-based
December 21, 2021
The next step in the company’s strategic plan, as well as swift moves to address regional pressures Accelerating into 2022, in accordance with the company’s three-year strategic plan, with a new Northern European leadership team and reset for the company’s German and U.K.